Aortic Aneurysm Market Forecast to Expand at a CAGR of 10.8% Through 2032

The global aortic aneurysm market was valued at approximately USD 4 billion in 2022 and is projected to reach USD 10.87 billion by 2032, growing at a CAGR of 10.8% from 2023 to 2032. Several factors are driving this growth. The increasing prevalence of atherosclerosis and the aging population are significant contributors. For instance, the rise in cardiovascular diseases and unhealthy lifestyles globally has led to an increase in aortic aneurysm cases, particularly among those aged 65 and older, where the aorta walls tend to weaken​.

Recent advancements in minimally invasive procedures, such as endovascular aneurysm repair (EVAR), are also bolstering market growth. These procedures offer reduced hospital stays, lower morbidity, and faster recovery times compared to traditional open surgeries, making them more attractive to both patients and healthcare providers​. Innovations in stent graft technologies, such as the FDA-approved AFX2 Endovascular AAA System by Endologix, are enhancing treatment efficacy and safety, further driving market expansion​.

However, the market faces challenges, including the high cost of advanced treatments and limited access to specialized care in developing regions. Device-related complications and the long-term durability of endovascular implants also pose significant hurdles​​. Despite these challenges, ongoing research and product innovations present substantial opportunities for growth, with companies focusing on developing new stent graft designs and conducting clinical trials to improve patient outcomes​​.

In summary, the aortic aneurysm market is poised for robust growth due to technological advancements, an aging population, and increasing incidences of cardiovascular diseases, despite the challenges that need to be addressed to fully realize its potential.

Key Takeaways

• The aortic aneurysm market is forecasted to grow at a 10.8% CAGR from 2023 to 2032, reaching USD 10.87 billion.
• Cardiovascular diseases caused 19.1 million deaths globally in 2020, driving the demand for aortic aneurysm treatments.
• Minimally invasive procedures, offering faster recovery, are boosting the market demand.
• Market segmentation includes TAA, AAA, stent-grafts, catheters, OSR, EVAR, and end-user categories.
• North America holds over 51% of the market share, supported by an established healthcare infrastructure.
• The Asia-Pacific region is experiencing the fastest market growth due to an aging population and increased healthcare spending.

Get Sample PDF Report: https://market.us/report/aortic-aneurysm-market/request-sample/

Aortic Aneurysm Market Key Segments

By Type

• Thoracic Aortic Aneurysm (TAA)
• Abdominal Aortic Aneurysm (AAA)

By Product Type

• Stent Grafts
• Catheters

By Treatment

• Open Surgical Repair (OSR)
• Endovascular Aneurysm Repair (EVAR)

By End-User

• Hospitals & Clinics
• Ambulatory Surgical Centers
• Other End-Users

Key Regions

• North America (The US, Canada, Mexico)
• Western Europe (Germany, France, The UK, Spain, Italy, Portugal, Ireland, Austria, Switzerland, Benelux, Nordic, Rest of Western Europe)
• Eastern Europe (Russia, Poland, The Czech Republic, Greece, Rest of Eastern Europe)
• APAC (China, Japan, South Korea, India, Australia & New Zealand, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, Rest of APAC)
• Latin America (Brazil, Colombia, Chile, Argentina, Costa Rica, Rest of Latin America)
• Middle East & Africa (Algeria, Egypt, Israel, Kuwait, Nigeria, Saudi Arabia, South Africa, Turkey, United Arab Emirates, Rest of MEA)

Buy Directly: https://market.us/purchase-report/?report_id=102305

Key Players Analysis

• Cardinal Health, through its subsidiary Cordis, plays a significant role in the aortic aneurysm market with its INCRAFT AAA Stent Graft System, designed for minimally invasive endovascular aneurysm repair (EVAR). This system is favored for its flexibility and ultra-low profile, making it suitable for complex anatomical structures. The company’s focus on technological advancements and patient-centric solutions enhances its competitive edge in providing effective treatments for abdominal aortic aneurysms (AAA)​.
• Medtronic is a key player in the aortic aneurysm market, offering a range of endovascular stent graft systems like the Endurant II/IIs for AAA and the Valiant Thoracic Stent Graft for thoracic aortic aneurysms (TAA). Their products are known for high procedural success rates and low complication risks. Medtronic’s continuous innovation in minimally invasive surgical techniques, coupled with robust global distribution, reinforces its leadership in the market​.
• Terumo Corporation is actively involved in the aortic aneurysm market, particularly with its RelayPro Thoracic Stent-Graft System approved by the FDA for treating TAA. Terumo’s commitment to innovation is evident through its PANTHER global research initiative, focusing on developing advanced surgical grafts. Their strategic emphasis on high-quality, minimally invasive solutions positions them as a key player in the evolving landscape of aortic aneurysm treatments​​.
• MicroPort Scientific Corporation provides a wide array of products for aortic aneurysm repair, with a strong presence in over 5,000 hospitals across 80 countries. Their focus on endovascular aneurysm repair (EVAR) devices, which offer less invasive treatment options, has contributed significantly to their market share. MicroPort’s efforts in expanding their product portfolio and enhancing distribution channels have solidified their position in the global aortic aneurysm market​.
• Cook Medical offers comprehensive solutions for both AAA and TAA through its Zenith endovascular stent graft systems. Known for their reliability and effectiveness, Cook’s products are widely used in various healthcare settings. The company continues to innovate and improve its devices, aiming to reduce procedural risks and enhance patient outcomes. Cook Medical’s commitment to quality and patient safety makes it a prominent player in the aortic aneurysm sector​.

Aortic Aneurysm Market Key Players:

• Cardinal Health
• Medtronic
• Terumo Corporation
• MicroPort Scientific Corporation
• Cook Medical
• Gore & Associates Inc.
• Endologix Inc.
• Jotec GmbH
• Cryolife Inc.
• LivaNova PLC
• Other Key Players

Aortic Aneurysm Market Report Scope >> Market Value (2023): USD 4 Billion || Forecast Revenue (2033): USD 11 Billion || CAGR (2024-2033): 10.8% || Base Year Estimation: 2023 || Historic Period: 2019-2022 || Forecast Period: 2024-2033.

Inquire More about report: https://market.us/report/aortic-aneurysm-market/#inquiry

About Market.US

Market.US is renowned for its comprehensive market research and analysis, providing customized and syndicated reports to a global clientele. Specializing in a variety of sectors, they offer strategic insights and detailed market forecasts, assisting businesses in making informed decisions. With a focus on innovation and accuracy, Market.US supports clients in over 126 countries, and maintains a strong repeat customer rate, underscoring their commitment to quality and client satisfaction. Their team excels in delivering exceptional research services, ensuring that no detail is overlooked in any target market.

Contact Details
Market.us (Powered By Prudour Pvt. Ltd.)
Contact No: +1 718 618 4351.
Email: inquiry@market.us
Blog: https://medicalmarketreport.com/

View More Trending Reports

Wearable Injectors Market Projected Surge To USD 20.9 Billion By 2033, With A Steady 12.4% CAGR

Medical Spa Market Projected To Reach USD 50.9 Billion With 13.2% CAGR By 2033

CAR-T Cell Therapies Market Hit USD 10.2 Billion By 2033

Condom Market Will Increase USD 17.9 Billion By 2032

Digital Therapeutics Market Size to Attain USD 62.4 Billion by 2032